These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16516167)
1. Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion. Lee JH; Park SY; Shin YW; Hong KW; Kim CD; Sung SM; Kim KY; Lee WS Brain Res; 2006 Apr; 1082(1):182-91. PubMed ID: 16516167 [TBL] [Abstract][Full Text] [Related]
2. Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunction with increased neuroprotection after chronic cerebral hypoperfusion in rats. Lee JH; Park SY; Shin YW; Kim CD; Lee WS; Hong KW Brain Res; 2007 Dec; 1185():246-55. PubMed ID: 17936728 [TBL] [Abstract][Full Text] [Related]
3. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Tomimoto H; Ihara M; Wakita H; Ohtani R; Lin JX; Akiguchi I; Kinoshita M; Shibasaki H Acta Neuropathol; 2003 Dec; 106(6):527-34. PubMed ID: 13680276 [TBL] [Abstract][Full Text] [Related]
4. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Watanabe T; Zhang N; Liu M; Tanaka R; Mizuno Y; Urabe T Stroke; 2006 Jun; 37(6):1539-45. PubMed ID: 16645134 [TBL] [Abstract][Full Text] [Related]
5. Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion. Edrissi H; Schock SC; Cadonic R; Hakim AM; Thompson CS Brain Res; 2016 Sep; 1646():494-503. PubMed ID: 27350079 [TBL] [Abstract][Full Text] [Related]
6. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia. Kwon KJ; Lee EJ; Kim MK; Kim SY; Kim JN; Kim JO; Kim HJ; Kim HY; Han JS; Shin CY; Han SH Neurobiol Dis; 2015 Jan; 73():12-23. PubMed ID: 25281785 [TBL] [Abstract][Full Text] [Related]
7. Expression of S100 protein and protective effect of arundic acid on the rat brain in chronic cerebral hypoperfusion. Ohtani R; Tomimoto H; Wakita H; Kitaguchi H; Nakaji K; Takahashi R Brain Res; 2007 Mar; 1135(1):195-200. PubMed ID: 17210147 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. Wang Q; Sun AY; Simonyi A; Jensen MD; Shelat PB; Rottinghaus GE; MacDonald RS; Miller DK; Lubahn DE; Weisman GA; Sun GY J Neurosci Res; 2005 Oct; 82(1):138-48. PubMed ID: 16075466 [TBL] [Abstract][Full Text] [Related]
9. Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Farkas E; Donka G; de Vos RA; Mihály A; Bari F; Luiten PG Acta Neuropathol; 2004 Jul; 108(1):57-64. PubMed ID: 15138777 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of neuregulin-1 in rat models of focal cerebral ischemia. Guo WP; Wang J; Li RX; Peng YW Brain Res; 2006 May; 1087(1):180-5. PubMed ID: 16616052 [TBL] [Abstract][Full Text] [Related]
11. Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat. Wakita H; Tomimoto H; Akiguchi I; Lin JX; Ihara M; Ohtani R; Shibata M Brain Res; 2003 Nov; 992(1):53-9. PubMed ID: 14604772 [TBL] [Abstract][Full Text] [Related]
12. Necrosis, apoptosis and hybrid death in the cortex and thalamus after barrel cortex ischemia in rats. Wei L; Ying DJ; Cui L; Langsdorf J; Yu SP Brain Res; 2004 Oct; 1022(1-2):54-61. PubMed ID: 15353213 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of catalpol on oligodendrocyte death and myelin breakdown in a rat model of chronic cerebral hypoperfusion. Cai QY; Chen XS; Zhan XL; Yao ZX Neurosci Lett; 2011 Jun; 497(1):22-6. PubMed ID: 21524686 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotection with intraventricular brain-derived neurotrophic factor in rat venous occlusion model. Takeshima Y; Nakamura M; Miyake H; Tamaki R; Inui T; Horiuchi K; Wajima D; Nakase H Neurosurgery; 2011 May; 68(5):1334-41. PubMed ID: 21307800 [TBL] [Abstract][Full Text] [Related]
15. Characterization of White Matter Injury in a Rat Model of Chronic Cerebral Hypoperfusion. Choi BR; Kim DH; Back DB; Kang CH; Moon WJ; Han JS; Choi DH; Kwon KJ; Shin CY; Kim BR; Lee J; Han SH; Kim HY Stroke; 2016 Feb; 47(2):542-7. PubMed ID: 26670084 [TBL] [Abstract][Full Text] [Related]
16. Pre-treatment and post-treatment with alpha-tocopherol attenuates hippocampal neuronal damage in experimental cerebral hypoperfusion. Annaházi A; Mracskó E; Süle Z; Karg E; Penke B; Bari F; Farkas E Eur J Pharmacol; 2007 Oct; 571(2-3):120-8. PubMed ID: 17597609 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of cyclosporin A on white matter changes in the rat brain after chronic cerebral hypoperfusion. Wakita H; Tomimoto H; Akiguchi I; Kimura J Stroke; 1995 Aug; 26(8):1415-22. PubMed ID: 7631347 [TBL] [Abstract][Full Text] [Related]
18. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. Cho KO; La HO; Cho YJ; Sung KW; Kim SY J Neurosci Res; 2006 Feb; 83(2):285-91. PubMed ID: 16385583 [TBL] [Abstract][Full Text] [Related]
19. Cilostazol but not sildenafil prevents memory impairment after chronic cerebral hypoperfusion in middle-aged rats. Godinho J; de Oliveira JN; Ferreira ED; Zaghi GG; Bacarin CC; de Oliveira RM; Milani H Behav Brain Res; 2015 Apr; 283():61-8. PubMed ID: 25623419 [TBL] [Abstract][Full Text] [Related]
20. Supra-additive neuroprotection by renexin, a mixed compound of ginkgo biloba extract and cilostazol, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion. Kwak PA; Lim SC; Han SR; Shon YM; Kim YI J Clin Neurol; 2012 Dec; 8(4):284-92. PubMed ID: 23323137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]